Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tian An MedicareCOLRF 43 Debt-to-Equity is 0.50 as of Dec. 2025, which is 4% below its 10-year median of 0.52. GuruFocus rates COLRF with a GF Score™ of 43/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 556 Healthcare Providers & Services companies, Tian An Medicare ranks worse than 53.96% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Tian An Medicare's Debt-to-Equity or its related term are showing as below:
COLRF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.44 Med: 0.52 Max: 1.34
Current: 0.5
During the past 13 years, the highest Debt-to-Equity Ratio of Tian An Medicare was 1.34. The lowest was 0.44. And the median was 0.52.
COLRF's Debt-to-Equity is ranked worse than 53.96% of 556
companies
in the Healthcare Providers & Services industry
Industry Median: 0.405
vs COLRF: 0.50
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Tian An Medicare Debt-to-Equity Related Terms
Tian An Medicare Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Tian An Medicare's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Tian An Medicare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tian An Medicare Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Tian An Medicare's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tian An Medicare (COLRF) has a Debt-to-Equity of 0.50 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Tian An Medicare and its competitors. This is near median its historical median of 0.52. Over the past decade, Tian An Medicare's Debt-to-Equity has ranged from 0.44 to 1.34. According to the industry distribution chart, Tian An Medicare ranks #300 out of 556 companies in the Healthcare Providers & Services industry, placing it in the top 54%.
Is Tian An Medicare's Debt-to-Equity too high?
Tian An Medicare's current Debt-to-Equity of 0.50 is near median its 10-year median of 0.52. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 1.34. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. Tian An Medicare's value of 0.50 is 23.5% above this industry median. Based on the distribution chart, Tian An Medicare ranks #300 out of 556 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tian An Medicare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #300 out of 556 companies for Debt-to-Equity. This places Tian An Medicare in the lower half of its industry. The industry median Debt-to-Equity is 0.41. Tian An Medicare's value of 0.50 is 23.5% above this benchmark. Historically, Tian An Medicare's own Debt-to-Equity has ranged from 0.44 to 1.34 over the past decade. While the company's 10-year median is 0.52 vs. the industry median of 0.41, Tian An Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tian An Medicare's current Debt-to-Equity of 0.50 is 23.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Tian An Medicare and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current Debt-to-Equity is 0.50, which is near median its own 10-year median of 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current Debt-to-Equity of 0.50. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current Debt-to-Equity is 0.50, which is near median its 10-year median of 0.52 and 23.5% above the Healthcare Providers & Services industry median of 0.41. Tian An Medicare's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current Debt-to-Equity is 0.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tian An Medicare (COLRF) Overvalued in 2026?
Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued.
The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.
Key valuation signals for COLRF:
Debt-to-Equity: 0.50 (near median its 10-year median of 0.52)
GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
Industry Position: 23.5% above the Healthcare Providers & Services median (#300 of 556)
No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
43GF Score
Get the complete analysis for COLRF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COLRF has been successfully added to your 
